~10 spots leftby Jun 2025

Contingency Management for Smoking Cessation

BT
Overseen byBenjamin Toll, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Medical University of South Carolina
Must be taking: Nicotine patch
Disqualifiers: Unstable psychiatric, Non-English, Pregnant, others
No Placebo Group
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Contingency Management for smoking cessation?

Research shows that using financial incentives, like prizes or vouchers, can help people quit smoking by rewarding them for not smoking. Studies found that people are more likely to stop smoking when they receive rewards for staying smoke-free, and this approach has been effective in various settings, including with pregnant women and socioeconomically disadvantaged individuals.12345

Is contingency management for smoking cessation safe for humans?

Contingency management, which includes methods like prize-based incentives, has been used safely in various settings, including with pregnant women and socioeconomically disadvantaged adults, without reported safety concerns.12678

How does the contingency management treatment for smoking cessation differ from other treatments?

Contingency management for smoking cessation is unique because it uses incentives, like money or prizes, to encourage people to quit smoking. This approach is different from traditional methods as it directly rewards individuals for maintaining abstinence, which can increase motivation and participation.123910

Research Team

BT

Benjamin Toll, PhD

Principal Investigator

Medical University of South Carolina

Eligibility Criteria

This trial is for adult smokers diagnosed with or suspected to have operable cancer, who are about to undergo surgery. Participants must smoke at least one cigarette daily and speak English. Those using alternative nicotine products, pregnant women, or individuals with unstable psychiatric/medical conditions cannot join.

Inclusion Criteria

I am 18 years old or older.
I have been diagnosed with or suspected to have a type of cancer that can be operated on.
You smoke at least one cigarette every day.

Exclusion Criteria

You use electronic cigarettes, snus, or other similar products that deliver nicotine.
I do not speak English.
I do not have any severe mental health issues like thoughts of suicide, psychosis, or dementia.
See 1 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive standard smoking cessation therapy including counseling and the nicotine patch. Half of the participants receive a novel smoking cessation treatment.

6 weeks

Follow-up

Participants are monitored for smoking abstinence through self-report, Carbon Monoxide Breath Monitoring, and Anabasine testing.

6 months

Treatment Details

Interventions

  • Contingency Management (Behavioural Intervention)
Trial OverviewThe study tests a new smoking cessation treatment against standard care in cancer patients facing surgery. Half will receive the novel treatment plus counseling and nicotine patches; the other half will get only the standard therapy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency ManagementExperimental Treatment1 Intervention
Group II: Standard CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

In a study involving 81 nicotine-dependent smokers, the addition of prize-based contingency management (CM) to standard care significantly reduced smoking during treatment compared to standard care alone.
However, these reductions in smoking did not persist after the treatment ended, indicating that while prize CM can be effective in the short term, it may not lead to long-term cessation.
Prize contingency management for smoking cessation: a randomized trial.Ledgerwood, DM., Arfken, CL., Petry, NM., et al.[2022]
Incentive and contingency management strategies have shown effectiveness in modifying smoking behavior, particularly in controlled settings, suggesting they can be beneficial for smoking cessation efforts.
Quit-and-win programs, which use incentives to encourage quitting, attract many participants and have produced modest quit rates, although the quality of evaluations varies and more rigorous studies are needed to confirm their effectiveness.
Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers.Donatelle, R., Hudson, D., Dobie, S., et al.[2006]
A contingency management procedure that rewards participants with accumulating money for abstaining from smoking led to a significantly higher likelihood of achieving a 48-hour period of abstinence compared to a procedure that deducted money for smoking.
Participants who earned money for continued abstinence were also less likely to miss appointments, indicating better engagement and adherence to the treatment program.
The relative contribution of economic valence to contingency management efficacy: a pilot study.Roll, JM., Howard, JT.[2021]

References

Prize contingency management for smoking cessation: a randomized trial. [2022]
Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. [2006]
The relative contribution of economic valence to contingency management efficacy: a pilot study. [2021]
Investigating group contingencies to promote brief abstinence from cigarette smoking. [2023]
Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment. [2022]
Greater perceived importance of earning abstinence-contingent incentives is associated with smoking cessation among socioeconomically disadvantaged adults. [2022]
Internet-based contingency management to promote smoking cessation: a randomized controlled study. [2022]
Internet-based self-tailored deposit contracts to promote smoking reduction and abstinence. [2018]
Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Vouchers versus prizes: contingency management treatment of substance abusers in community settings. [2016]